The latest developments in the field of therapeutic delivery, December 2020-Reference-Cited by-同舟云学术

The latest developments in the field of therapeutic delivery, December 2020

Published:2021-04 Issue:4 Volume:12 Page:271-285
ISSN:2041-5990
Container-title:Therapeutic Delivery
language:en
Short-container-title:Therapeutic Delivery

Author:

Timmins Peter¹^ORCID

Affiliation:

1. Department of Pharmacy, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Link

https://www.future-science.com/doi/pdf/10.4155/tde-2021-0013

Reference71 articles.

1. Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody–Drug Conjugates. www.nbe-therapeutics.com/newsroom/news-press-releases/2020/2020-12-10

2. NBE-Therapeutics, Technology overview. www.nbe-therapeutics.com/technology/overview

3. Gilead Sciences to Acquire MYR GmbH. www.gilead.com/news-and-press/press-room/press-releases/2020/12/gilead-sciences-to-acquire-myr-gmbh

4. Lilly Announces Agreement to Acquire Prevail Therapeutics. http://lilly.mediaroom.com/index.php?s=9042&item=138139

5. Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program. https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-exclusive-license-agreement-gsk-novel

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Most Recent Discoveries in Heterocyclic Nanoformulations for Targeted Anticancer Therapy;Mini-Reviews in Medicinal Chemistry;2022-07

2. Novel therapeutic targets and agents for pediatric dyslipidemia;Therapeutic Advances in Endocrinology and Metabolism;2021-01